Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Eksterne analyser

Generic: A rare miss in Q2 - ABG

Generic Sweden

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier.

Download analyse (PDF)
Slower sales growth than we have become used to

We lower long-term EBIT by 5%

Lifted COVID-19 restrictions boost new sales

Q2: Net sales +6% y-o-y, EBIT margin of 17.2% (20.4%)
Generic reported Q2 net sales of SEK 31.3m (29.6), representing a slower growth rate than we have become accustomed to. A combination of tough comparables alongside a slightly lower growth rate from existing customer explains the lower growth rate. Net sales were 4% behind ABGSCe, a rare miss from Generic. EBIT was SEK 5.4m (6.0m) for a margin of 17.2% (20.4%). We expected a lower EBIT margin based on a need to strengthen the organisation with additional employees, but still forecasted 17.7%. Looking forward, the company thinks it will benefit from lifted COVID-19 restrictions given that trade shows, events and physical meetings are important for its ability to sign new customers. We think this is a viable explanation and at least partly explains the relative paucity of new deals during the pandemic.

Still well-positioned, but negative revisions to forecast
We are not that worried about the Q2 miss, as we think digital communication will be increasingly important for a lot of companies in the years to come. In Q2’21, Generic onboarded the Swedish Social Insurance Agency as a new customer, driving additional sales. The company also benefitted from additional messaging volumes during 2021 which is why it may take a quarter or two to reach back to +10% sales growth, but we think the possibility is still there in the medium-term. However, we do lower our sales estimates by 2-4% for ’22-‘24e, respectively, and EBIT for the same period by 4-5%.

Trading below its own historical valuation
The Q2 shortfall did not go unnoticed by the market with the stock down 18% on the day of the report and -32% over the last month. We note that the valuation multiples have decreased significantly and that Generic is now trading more than 50% below its own two-year historical multiples for EV/EBIT NTM.
Läs mer på ABG Sundal Collier
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team